Freestone Capital Holdings, LLC

SEC CIK: 0001470876
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

NKTR holding history

Nektar Therapeutics in every 13F filed by Freestone Capital Holdings, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overview All 13F holders of NKTR Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2023

Holdings of NKTR by Freestone Capital Holdings, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−20,000−100.0%	Sold out	Holders
Q4 2023	20,000	$11.3K	<0.1%	00.0%	Unchanged	Holders
Q3 2023	20,000	$11.9K	<0.1%	+20,000	New	Holders